These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Tetracycline treatment of acne vulgaris with special reference to the methodical respects of a double blind study]. Kanaar P; Zelvelder WG; van Delden J; van de Staak WJ Hautarzt; 1972 Aug; 23(8):345-9. PubMed ID: 4264333 [No Abstract] [Full Text] [Related]
23. Cellular immunity in acne vulgaris during transfer factor treatment. Ashorn R; Uotila A; Kuokkanen K; Räsänen L; Karhumäki E; Krohn K Ann Clin Res; 1985; 17(4):152-5. PubMed ID: 2934019 [TBL] [Abstract][Full Text] [Related]
24. Common and alternate oral antibiotic therapies for acne vulgaris: a review. Amin K; Riddle CC; Aires DJ; Schweiger ES J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358 [TBL] [Abstract][Full Text] [Related]
25. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. Leyden JJ; Krochmal L; Yaroshinsky A J Am Acad Dermatol; 2006 Jan; 54(1):73-81. PubMed ID: 16384759 [TBL] [Abstract][Full Text] [Related]
26. An acne grading method using photographic standards. Cook CH; Centner RL; Michaels SE Arch Dermatol; 1979 May; 115(5):571-5. PubMed ID: 156006 [TBL] [Abstract][Full Text] [Related]
27. A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. Leyden J; Bergfeld W; Drake L; Dunlap F; Goldman MP; Gottlieb AB; Heffernan MP; Hickman JG; Hordinsky M; Jarrett M; Kang S; Lucky A; Peck G; Phillips T; Rapaport M; Roberts J; Savin R; Sawaya ME; Shalita A; Shavin J; Shaw JC; Stein L; Stewart D; Strauss J; Swinehart J; Swinyer L; Thiboutot D; Washenik K; Weinstein G; Whiting D; Pappas F; Sanchez M; Terranella L; Waldstreicher J J Am Acad Dermatol; 2004 Mar; 50(3):443-7. PubMed ID: 14988688 [TBL] [Abstract][Full Text] [Related]
28. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723 [TBL] [Abstract][Full Text] [Related]
29. The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study. Iraji F; Momeni A; Naji SM; Siadat AH Dermatol Online J; 2006 Mar; 12(3):26. PubMed ID: 16638440 [TBL] [Abstract][Full Text] [Related]
30. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris. Marazzi P; Boorman GC; Donald AE; Davies HD J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873 [TBL] [Abstract][Full Text] [Related]
32. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris. Stotland M; Shalita AR; Kissling RF Am J Clin Dermatol; 2009; 10(4):221-7. PubMed ID: 19489655 [TBL] [Abstract][Full Text] [Related]
33. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Sagransky M; Yentzer BA; Feldman SR Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357 [TBL] [Abstract][Full Text] [Related]
35. [Clinical observations on the action of a new drug against acne]. Fuga GC Minerva Med; 1967 Apr; 58(29):1241-4. PubMed ID: 4228593 [No Abstract] [Full Text] [Related]